Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Açın
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1.091,51
-2,30
-0,21%
1.093,811.096,521.100,221.091,51
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
608,77608,77612,97608,77
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1.237,98
-16,83
-1,34%
1.254,811.253,011.253,871.226,33
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1.744,71
-16,40
-0,93%
1.761,111.764,271.766,881.744,71
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
642,58644,87648,48640,18
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
851,13855,66858,75845,56
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
217,98217,98218,65216,88
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3.260,69
+48,86
+1,52%
3.211,833.227,213.268,383.226,55
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
948,98948,58957,83941,97
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1.466,80
-7,72
-0,52%
1.474,521.479,031.481,041.466,80
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2.397,50
+5,38
+0,22%
2.392,122.396,952.421,222.382,32
PTGX:NASDAQ
Protagonist Therapeutics Inc
98,37 US$
-0,61%
(-0,60) 1D
98,37 US$
0,00% (0,00)
After hours
Closed: 1 may, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PTGX...
Açın
99,16 US$
High
99,46 US$
Low
97,08 US$
Mkt. cap
6,33 mlrd
Avg. vol.
893,94K
Volume
447,70K
52-wk high
107,84 US$
52-wk low
41,28 US$
EPS
-2,05 US$
Beta
2,12
Shares outstanding
63,81 mln
No. of employees
132
News stories
From sources across the web
About Protagonist Therapeutics Inc
CEO-
Employees132
Founded2006
HeadquartersNewark, Kaliforniya, Amerika Birləşmiş Ştatları
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
mar 2025
iyn 2025
sen 2025
dek 2025
Revenue
28,32 mln
5,55 mln
4,71 mln
7,44 mln
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
35,89 mln
37,04 mln
40,00 mln
46,36 mln
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11,74 mln
10,55 mln
11,13 mln
11,43 mln
Operating expense
47,63 mln
47,59 mln
51,13 mln
57,79 mln
Total operating expenses
47,63 mln
47,59 mln
51,13 mln
57,79 mln
Operating income
-19,31 mln
-42,04 mln
-46,42 mln
-50,36 mln
Other non operating income
-
-
-
27,00K
EBT including unusual items
-11,66 mln
-34,60 mln
-39,34 mln
-43,72 mln
EBT excluding unusual items
-11,66 mln
-34,60 mln
-39,34 mln
-43,72 mln
Income tax expense
-
172,00K
-
666,00K
Effective tax rate
-
-0,50%
-
-1,52%
Other operating expenses
-
-
-
-
Net income
-11,66 mln
-34,77 mln
-39,34 mln
-44,38 mln
Net profit margin
-41,15%
-626,96%
-834,87%
-596,80%
Earnings per share
-0,19
-0,55
-0,62
-0,69
Interest and investment income
7,57 mln
7,41 mln
7,05 mln
6,76 mln
Interest expense
-
-
-
-
Net interest expenses
7,57 mln
7,41 mln
7,05 mln
6,76 mln
Depreciation and amortization charges
-
-
-
-
EBITDA
-19,07 mln
-41,74 mln
-46,06 mln
-49,98 mln
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more